Global Genome Perturbation Tools Market – Industry Trends and Forecast to 2030

Get Exclusive Sample PDF of this Report Here

Genome Perturbation Tools Market Analysis and Size

According to National Center for Advancing Translational Sciences updates from June 2022, the National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Program has awarded 24 more grants to researchers across the United States and Canada. Over the next four years, the SCGE Program will award USD 89 million in advance genome editing donations. This brings the total number of projects supported to 45, with a funding calculation of approximately USD 190 million spread out over six years. Such grants from national institutes contribute to the market's growth during the forecast period.

Data Bridge Market Research analyses that the genome perturbation tools market, which was USD 1 billion in 2022, is expected to reach USD 2.07 billion by 2030, at a CAGR of 9.50% from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Genome Perturbation Tools Market Scope and Segmentation

Get Exclusive Sample PDF of this Report Here

Market Definition

Genome perturbation tools are genetic perturbation platforms, formerly known as the RNA interference platform, that functional aid investigation of the mammalian genome revealing how genetic alterations lead to phenotypic variations. To support these investigations, the platform creates gene-editing technologies such as CRISPR/Cas9 constructs libraries, short hairpin RNAs (shRNAs), and open reading frames (ORFs) to edit, knock down, or overexpress genes.

Global Genome Perturbation Tools Market Dynamics

Drivers

• Increase in adoption of genome perturbation tools

The increasing adoption of genome perturbation tools for cancer diagnosis and increased research in biotechnology is due to increased cases of diseases such as genetic disorders and cancers. Furthermore, the introduction of fourth-generation sequencing, the low cost of DNA sequencing analysis, and the surge in application from emerging markets are some factors that will drive the genome perturbation tools market during the forecast period.

• Rising use of CRISPR-Cas9

The introduction of CRISPR-Cas9, a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence easily, is primarily responsible for the increase in the number and scope of genome editing technology applications. The ease of use of the CRISPR platform compared to previous technologies has resulted in its widespread adoption and application. Genome editing could positively impact sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases because of these advancements.

Opportunities

• Growing number of research and development activities

Several oncological studies and research have gone into developing the best gene-editing tool for cancer treatment. CRISPR-CAS9 has been created to engineer oncolytic viruses and immune cells for therapeutic purposes. It easily and precisely edits the gene in model organisms and humans. The techniques are highly customizable and are being used in several medical labs worldwide, which will help the market grow in the coming years.

Restraints/Challenges

• High cost and ethical concerns

Genomic instruments have advanced features and added functionalities, so the price is usually premium and set at a higher rate. The technology is cutting-edge. Many pharmaceutical companies and research laboratories spend a lot of money to get genome editing tools.

Lack of technology implementation and usage of conventional genomics are hampering the growth of the genome perturbation tools market in the above-mentioned forecast period.

This genome perturbation tools market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the genome perturbation tools market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Genome Perturbation Tools Market Scope

The genome perturbation tools market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Instruments

Mode

• Automated
• Semi-automated
• Manual

Type

• Sequencing platform
• IHC
• Microscopy
• Flow cytometry
• Mass spectrometry
• Others
• Consumables
• Software
• Bioinformatics tools
• Imaging tools
• Storage
• Management databases

Application

• Translational Research
• Academic Customers
• Diagnostic Customers
• Pharmaceutical Manufacturer

Genome Perturbation Tools Market Regional Analysis/Insights

The genome perturbation tools market is analysed and market size insights and trends are provided by country, type and application as referenced above.

The countries covered in the genome perturbation tools market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genome perturbation tools market due to the increasing research activities and adoption spatial profiling in cancer diagnosis.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030, owing to the growing investment by market players to develop the regulatory network.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The genome perturbation tools market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genome perturbation tools market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genome perturbation tools market. The data is available for historic period 2011-2021.

Competitive Landscape and Genome Perturbation Tools Market Share Analysis

The genome perturbation tools market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to genome perturbation tools market.

Some of the major players operating in the genome perturbation tools market are:

• 10x Genomics (U.S.)
• Dovetail Genomics (U.S.)
• Illumina, Inc (U.S.)
• NanoString (U.S.)
• OriGene Technologies, Inc. (U.S.)
• Seven Bridges Genomics (U.S.)
• Horizon Discovery Ltd. (U.K.)
• Advanced Cell Diagnostics, Inc. (U.S.)
• Eiken Chemical Co., Ltd. (Japan)

SKU-52415